141 related articles for article (PubMed ID: 17656181)
1. Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners.
Trottier S; Omar RF; Désormeaux A; Drouin J; Gagnon MT; Vezina F; Guilbert E; Mâsse B; Bergeron MG
Contraception; 2007 Aug; 76(2):117-25. PubMed ID: 17656181
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Giguere JF; Domingo MC; Piret J; Tsague L; Zekeng L; Mwatha A; Mâsse B; Bergeron MG
Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725
[TBL] [Abstract][Full Text] [Related]
3. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study.
Schwartz JL; Mauck C; Lai JJ; Creinin MD; Brache V; Ballagh SA; Weiner DH; Hillier SL; Fichorova RN; Callahan M
Contraception; 2006 Aug; 74(2):133-40. PubMed ID: 16860051
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.
Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Domingo MC; Giguère JF; Piret J; Mwatha A; Mâsse B; Bergeron MG
Contraception; 2010 Jan; 81(1):79-85. PubMed ID: 20004278
[TBL] [Abstract][Full Text] [Related]
5. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
[TBL] [Abstract][Full Text] [Related]
6. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.
Mayer KH; Maslankowski LA; Gai F; El-Sadr WM; Justman J; Kwiecien A; Mâsse B; Eshleman SH; Hendrix C; Morrow K; Rooney JF; Soto-Torres L;
AIDS; 2006 Feb; 20(4):543-51. PubMed ID: 16470118
[TBL] [Abstract][Full Text] [Related]
9. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences.
Hardy E; Hebling EM; Sousa MH; Almeida AF; Amaral E
Contraception; 2007 Aug; 76(2):126-31. PubMed ID: 17656182
[TBL] [Abstract][Full Text] [Related]
10. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
Doh AS; Ngoh N; Roddy R; Lai JJ; Linton K; Mauck C
Contraception; 2007 Sep; 76(3):245-9. PubMed ID: 17707724
[TBL] [Abstract][Full Text] [Related]
11. A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.
Ballagh SA; Brache V; Mauck C; Callahan MM; Cochon L; Wheeless A; Moench TR
Contraception; 2008 Feb; 77(2):130-7. PubMed ID: 18226678
[TBL] [Abstract][Full Text] [Related]
12. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
[TBL] [Abstract][Full Text] [Related]
14. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
[TBL] [Abstract][Full Text] [Related]
15. Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models.
Piret J; Laforest G; Bussières M; Bergeron MG
J Appl Toxicol; 2008 Mar; 28(2):164-74. PubMed ID: 17549701
[TBL] [Abstract][Full Text] [Related]
16. Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.
Malonza IM; Mirembe F; Nakabiito C; Odusoga LO; Osinupebi OA; Hazari K; Chitlange S; Ali MM; Callahan M; Van Damme L
AIDS; 2005 Dec; 19(18):2157-63. PubMed ID: 16284466
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
van der Straten A; Napierala S; Cheng H; Mauck C; Depineres T; Dhlakama P; Thompson M; Chipato T; Hammond N; Padian N
Contraception; 2007 Nov; 76(5):389-99. PubMed ID: 17963865
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States.
Mayer KH; Peipert J; Fleming T; Fullem A; Moench T; Cu-Uvin S; Bentley M; Chesney M; Rosenberg Z
Clin Infect Dis; 2001 Feb; 32(3):476-82. PubMed ID: 11170957
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of Carraguard vaginal gel use among Thai couples.
Whitehead SJ; Kilmarx PH; Blanchard K; Manopaiboon C; Chaikummao S; Friedland B; Achalapong J; Wankrairoj M; Mock P; Thanprasertsuk S; Tappero JW
AIDS; 2006 Nov; 20(17):2141-8. PubMed ID: 17086053
[TBL] [Abstract][Full Text] [Related]
20. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
Frezieres RG; Walsh T; Kilbourne-Brook M; Coffey PS
Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]